论文部分内容阅读
目的:探讨依达拉奉注射液治疗急性脑梗死的临床疗效。方法:收治51例急性脑梗死患者,随机分为对照组和治疗组。对照组给予常规治疗,治疗组在常规治疗基础上加用依达拉奉注射液,分别评价治疗前后2组临床疗效。结果:治疗1个疗程后,治疗组临床疗效总有效率81.5%,恶化1例,对照组临床疗效总有效率74.8%,恶化2例。两组临床疗效总有效率比较,差异有统计学意义,P<0.05。结论:在急性脑梗发病的早期选用依达拉奉治疗可提高临床疗效,值得借鉴。
Objective: To investigate the clinical efficacy of edaravone injection in the treatment of acute cerebral infarction. Methods: Fifty-one patients with acute cerebral infarction were randomly divided into control group and treatment group. The control group was given conventional treatment. The treatment group was given edaravone injection on the basis of routine treatment, and the clinical curative effect was evaluated respectively before and after treatment. Results: After a course of treatment, the total effective rate of clinical treatment was 81.5% in the treatment group, 1 case of deterioration. The total effective rate of the control group was 74.8% and 2 cases were deteriorated. The total effective rate of clinical efficacy between the two groups, the difference was statistically significant, P <0.05. Conclusion: The treatment of edaravone in the early stage of acute cerebral infarction may improve the clinical curative effect, and it is worth learning from.